scout
|Videos|April 29, 2015

Impact of Bevacizumab in Ovarian Cancer

Robert L. Coleman, MD, FACOG, FACS, professor, Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, discusses a study which examined the impact of bevacizumab in ovarian cancer.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME